Andréas Mackensen

23.4k total citations · 5 hit papers
253 papers, 11.0k citations indexed

About

Andréas Mackensen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Andréas Mackensen has authored 253 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Immunology, 121 papers in Oncology and 62 papers in Molecular Biology. Recurrent topics in Andréas Mackensen's work include CAR-T cell therapy research (91 papers), Immune Cell Function and Interaction (77 papers) and Immunotherapy and Immune Responses (72 papers). Andréas Mackensen is often cited by papers focused on CAR-T cell therapy research (91 papers), Immune Cell Function and Interaction (77 papers) and Immunotherapy and Immune Responses (72 papers). Andréas Mackensen collaborates with scholars based in Germany, United States and Switzerland. Andréas Mackensen's co-authors include Christian U. Blank, Reinhard Andreesen, Marina Kreutz, Eva Gottfried, Dimitrios Mougiakakos, Simon Voelkl, Karin Fischer, Thomas F. Gajewski, Norbert Meidenbauer and Leoni A. Kunz‐Schughart and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andréas Mackensen

241 papers receiving 10.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibitory effect of tumor cell–derived lactic acid on human T cells

2007 1.5k citations Norbert Meidenbauer, Andréas Mackensen et al. Blood profile →
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression

2005 566 citations Reinhard Andreesen, Andréas Mackensen et al. Blood profile →
CAR T-cell therapy in autoimmune diseases

2023 195 citations Andréas Mackensen, Dimitrios Mougiakakos et al. profile →
Advancements and challenges in CAR T cell therapy in autoimmune diseases

2024 85 citations Fabian Müller, Andréas Mackensen et al. profile →
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells

2025 15 citations Fabian Müller, Simon Völkl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andréas Mackensen Germany	52	6.5k	5.0k	3.4k	1.6k	773	253	11.0k
Paul M. Sondel United States	60	6.7k 1.0×	4.7k 0.9×	3.5k 1.0×	1.1k 0.7×	1.1k 1.4×	334	12.2k
Taha Merghoub United States	54	6.3k 1.0×	6.9k 1.4×	4.3k 1.3×	1.3k 0.8×	1.2k 1.6×	210	12.5k
Peter J. Nelson Germany	67	4.6k 0.7×	3.9k 0.8×	4.8k 1.4×	1.7k 1.0×	1.1k 1.4×	252	13.8k
Barbara Seliger Germany	65	8.1k 1.3×	6.3k 1.3×	5.3k 1.6×	1.8k 1.1×	896 1.2×	362	15.2k
Joachim W. Ellwart Germany	48	4.6k 0.7×	3.7k 0.7×	4.2k 1.2×	1.2k 0.8×	486 0.6×	87	11.1k
Vassiliki A. Boussiotis United States	61	9.5k 1.5×	5.5k 1.1×	3.8k 1.1×	1.3k 0.8×	744 1.0×	182	15.6k
Ann Richmond United States	62	5.4k 0.8×	6.3k 1.3×	5.1k 1.5×	1.9k 1.2×	485 0.6×	166	12.9k
Ena Wang United States	67	7.2k 1.1×	6.3k 1.3×	5.4k 1.6×	2.0k 1.2×	1.4k 1.8×	260	14.2k
Jonathan Cebon Australia	62	6.6k 1.0×	6.3k 1.3×	4.7k 1.4×	943 0.6×	1.4k 1.8×	278	13.6k
Hamid Band United States	60	4.0k 0.6×	3.0k 0.6×	6.1k 1.8×	959 0.6×	580 0.8×	199	11.4k

Countries citing papers authored by Andréas Mackensen

Since Specialization

Citations

This map shows the geographic impact of Andréas Mackensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andréas Mackensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andréas Mackensen more than expected).

Fields of papers citing papers by Andréas Mackensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andréas Mackensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andréas Mackensen. The network helps show where Andréas Mackensen may publish in the future.

Co-authorship network of co-authors of Andréas Mackensen

This figure shows the co-authorship network connecting the top 25 collaborators of Andréas Mackensen. A scholar is included among the top collaborators of Andréas Mackensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andréas Mackensen. Andréas Mackensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mackensen, Andréas, Winfried Alsdorf, Daniel Heudobler, et al.. (2024). 611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors. Annals of Oncology. 35. S489–S490. 7 indexed citations

Böttcher, Martin, Andrej Stoll, Simon Völkl, et al.. (2024). Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(6). 628.e1–628.e9. 1 indexed citations

Reimann, Hannah, Kilian Schober, Johan Verhagen, et al.. (2023). Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains. Immunobiology. 228(5). 152720–152720. 1 indexed citations

Parker, Scott, et al.. (2023). Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response. Cell Death and Disease. 14(8). 561–561. 5 indexed citations

Liang, Chunguang, Romy Loschinski, Andrej Stoll, et al.. (2023). Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT. Blood. 141(13). 1626–1639. 8 indexed citations

Meidenbauer, Norbert, Frank Kunath, Peter J. Goebell, et al.. (2022). New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial. Journal of Clinical Medicine. 11(15). 4558–4558. 5 indexed citations

Karg, Margarete M., Lukas John, Barbara C. Böck, et al.. (2022). Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma. Molecular Cancer Research. 20(8). 1320–1336. 4 indexed citations

Stoll, Andrej, Heiko Bruns, Maximilian Fuchs, et al.. (2021). CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity. Leukemia. 35(12). 3482–3496. 29 indexed citations

Kremer, Andreas E., Carsten Willam, Simon Völkl, et al.. (2021). Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity. European Journal of Immunology. 51(10). 2478–2484. 4 indexed citations

10.

Böttcher, Martin, Andrej Stoll, Romy Loschinski, et al.. (2020). Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling. Cancer Research. 80(17). 3663–3676. 49 indexed citations

11.

Kremer, Anita N., Ellie G.A. Lurvink, Andreas E. Kremer, et al.. (2020). Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase. Frontiers in Immunology. 11. 381–381. 5 indexed citations

12.

Böttcher, Martin, et al.. (2020). Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas. Frontiers in Oncology. 10. 594782–594782. 22 indexed citations

13.

Schaffer, Stefanie, Simon Völkl, Katrin Peter, et al.. (2019). Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Molecular Cancer Therapeutics. 19(2). 409–419. 25 indexed citations

14.

Bosch, Jacobus J., Joseph Tickle, Ka‐Kit Li, et al.. (2017). Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13. The Journal of Immunology. 199(5). 1672–1681. 10 indexed citations

15.

Mougiakakos, Dimitrios, Domenica Saul, Martina Braun, et al.. (2017). CD33/CD3-Bispecific T-Cell Engaging (BiTE®) Antibody Constructs Efficiently Target Monocytic CD14+ hla-DRlow IDO+ aml-MDSCs. Blood. 130. 1363–1363. 2 indexed citations

16.

Bruns, Heiko, Catherine Bessell, Juan Carlos Varela, et al.. (2015). CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells. Clinical Cancer Research. 21(9). 2075–2083. 21 indexed citations

17.

Grube, Matthias, Ellen C. Obermann, Katayoun Rezvani, et al.. (2007). CD8+ T cells Reactive to Survivin Antigen in Patients with Multiple Myeloma. Clinical Cancer Research. 13(3). 1053–1060. 27 indexed citations

18.

Walton, Senta M., Marco Gerlinger, Olga de la Rosa, et al.. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. The Journal of Immunology. 177(11). 8212–8218. 21 indexed citations

19.

Meidenbauer, Norbert, et al.. (2003). Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients. The Journal of Immunology. 170(4). 2161–2169. 124 indexed citations

20.

Oelke, Mathias, et al.. (2000). Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.. PubMed. 6(5). 1997–2005. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact